Guidelines on the investigation and management of antiphospholipid syndrome.
about
Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeAntiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndromeThe Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome.Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.Diagnosis of antiphospholipid syndrome in routine clinical practicePregnancy loss and thrombophilia: the elusive link.Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature review.Indications for IVIG in rheumatic diseasesLupus anticoagulants and anticardiolipin antibodies in Indian women with spontaneous, recurrent fetal lossRivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.Mitral valve replacement in systemic lupus erythematosus associated Libman-Sacks endocarditis.Antiphospholipid Syndrome - A Case Report of Pulmonary Thromboembolism, Followed with Acute Myocardial Infarction in Patient with Systemic Sclerosis.Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease.Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?Antiphospholipid antibody testing and standardization.Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.LMWH to prevent placenta-mediated pregnancy complications: an update.Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis.Pearls and pitfalls in factor inhibitor assays.The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review.ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.The challenges of lupus anticoagulants.The aspirin story - from willow to wonder drug.Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?Acquired hemophilia A: Updated review of evidence and treatment guidance.The Laboratory Diagnosis of the Antiphospholipid Syndrome.Pathogenesis and management of antiphospholipid syndrome.Segmental small bowel necrosis associated with antiphospholipid syndrome: a case report.The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays: A Large, Retrospective Study at a Coagulation Reference Laboratory.Plasmodium spp. and Borrelia burgdorferi co-infection associated with antiphospholipid syndrome in a returned traveler: a case report.Non-haemorrhagic, bilateral adrenal infarction in a patient with antiphospholipid syndrome along with lupus myocarditis.Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).Current practices for lupus anticoagulant testing at a tertiary care hospital and impact on laboratory resources.Genetic Risk Factors in Venous Thromboembolism.
P2860
Q24185813-5553A698-9399-435B-8961-0414454ECA37Q24185949-38DB9A95-2147-4C72-B918-ACE0FEDF3EEBQ33781136-B3EAAD99-D284-4038-87D0-E909AC617865Q33875897-4426DBA3-72D0-4862-83F9-92310B6EEED9Q33939826-304CAC7C-50FF-4329-8FDC-E1E3CACDB917Q34263740-E73EA087-8E64-435C-BFB0-7E2A2043BB89Q34761674-A3D54D19-EFEA-4EFB-AA8E-448B8C5D773FQ35102141-12B0ED73-39B3-4E46-8335-B9E90778826BQ35220821-55DFD196-AE6C-472C-81C7-6C3009DA7DC1Q35925359-0220CB42-C2A3-4283-97DF-D7B6F207520FQ36017106-E88551FF-2DB6-4371-B580-09B87A699F80Q36717709-970D3B41-3E24-40AB-98CB-54D1FEEDC859Q36929504-F424C6AA-AEF9-4FB7-818F-583E23171FBCQ37230504-DC7B0586-0908-4DDC-9EEA-1C214D03F068Q37640945-2CBE7D8B-7253-4F57-B370-8490329825FDQ37730681-606C5FEA-B98A-4A7E-AF5E-B6EBB4CCF436Q38193203-FE03D654-3737-4A34-9F1C-1791FDCD4941Q38205953-0C388175-1FC9-4E8F-A5E7-76C4ED7309D9Q38205954-688988EA-0644-4548-95D5-B16C960FE9D5Q38237932-CEE95395-40D6-4591-B859-7FC0AA3D5C0AQ38268419-497766AD-08BD-4BC2-BF53-CD2E86FFB64BQ38273875-6EE67265-098A-4882-9FBB-A176121C6B2BQ38481939-E75A4901-C768-4556-95C1-5F8E07F4626BQ38570944-C111AFB0-A932-44A5-9DA2-6E39AD82A2ADQ38596401-514919A3-1D36-4D11-A6D1-E7E5500BC38DQ38656360-93369B4D-7203-43D7-B51E-6B74119449B9Q38703934-AEFD4671-4F0C-49DF-9D02-39B5EF2400DDQ38768065-516DF2E9-CA19-4E69-B282-7ABB1B5C9A9EQ38794847-6854DC7A-73D1-46F8-984C-25A225CBE5FAQ38805567-8B98F7D4-3007-4746-9F8E-85A11CC01820Q39134202-CE2E83E5-A259-47C2-B9E2-B9A1073B22BBQ39198671-F273CE53-CBBB-4B7A-89C9-C4F285E66C40Q39237507-BF311F04-3A99-4D0C-8672-81AEA8F455B7Q39318344-C8A64225-39BD-43DD-BA37-23E14D32BC7BQ40061610-07494D4A-5F3D-4ABE-A7D9-C214DB94EB78Q40095811-3C11D6FB-517F-40EA-B2D0-74916CE7FB73Q40221778-CBFACEA2-6C62-4E35-AAE9-9F3E73FA1AF2Q40323287-FD72482D-739F-4C75-9F64-E509021F9E80Q40386785-5DF6F972-FB20-4BC7-9A9B-3FB0744E4B18Q40577579-6077B46E-9AB1-48E3-820B-0A5D5D0E8834
P2860
Guidelines on the investigation and management of antiphospholipid syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Guidelines on the investigation and management of antiphospholipid syndrome.
@en
Guidelines on the investigation and management of antiphospholipid syndrome.
@nl
type
label
Guidelines on the investigation and management of antiphospholipid syndrome.
@en
Guidelines on the investigation and management of antiphospholipid syndrome.
@nl
prefLabel
Guidelines on the investigation and management of antiphospholipid syndrome.
@en
Guidelines on the investigation and management of antiphospholipid syndrome.
@nl
P2093
P2860
P1476
Guidelines on the investigation and management of antiphospholipid syndrome.
@en
P2093
David Keeling
Gary W Moore
Ian A Greer
Ian Mackie
Michael Greaves
P2860
P356
10.1111/J.1365-2141.2012.09037.X
P407
P577
2012-02-08T00:00:00Z